178 related articles for article (PubMed ID: 15985257)
21. Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
Kaunitz AM; Stern L; Doyle J; Etschmaie MR
Manag Care Interface; 2007 Mar; 20(3):47-50. PubMed ID: 17458481
[TBL] [Abstract][Full Text] [Related]
22. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
23. Long-term use of the levonorgestrel-releasing intrauterine system.
Inki P
Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
[TBL] [Abstract][Full Text] [Related]
24. Current treatment options for abnormal uterine bleeding: an evidence-based approach.
Istre O; Qvigstad E
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):905-13. PubMed ID: 17499553
[TBL] [Abstract][Full Text] [Related]
25. [Alternatives to hysterectomy: a review].
Gaetje R
Zentralbl Gynakol; 2004 Jun; 126(3):119-24. PubMed ID: 15236094
[TBL] [Abstract][Full Text] [Related]
26. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
27. Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma.
Jacobson GF; Shaber RE; Armstrong MA; Hung YY
Am J Obstet Gynecol; 2007 Jun; 196(6):601.e1-5; discussion 601.e5-6. PubMed ID: 17547914
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.
Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
Lancet; 2001 Jan; 357(9252):273-7. PubMed ID: 11214131
[TBL] [Abstract][Full Text] [Related]
29. Treatment of menorrhagia.
Apgar BS; Kaufman AH; George-Nwogu U; Kittendorf A
Am Fam Physician; 2007 Jun; 75(12):1813-9. PubMed ID: 17619523
[TBL] [Abstract][Full Text] [Related]
30. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
[TBL] [Abstract][Full Text] [Related]
31. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
32. Indications and alternatives to hysterectomy.
Solnik MJ; Munro MG
Clin Obstet Gynecol; 2014 Mar; 57(1):14-42. PubMed ID: 24488051
[TBL] [Abstract][Full Text] [Related]
33. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
[TBL] [Abstract][Full Text] [Related]
34. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Varma R; Sinha D; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):9-28. PubMed ID: 16325993
[TBL] [Abstract][Full Text] [Related]
35. Medical and surgical management of adenomyosis.
Farquhar C; Brosens I
Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):603-16. PubMed ID: 16563872
[TBL] [Abstract][Full Text] [Related]
36. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
37. Abnormal uterine bleeding: managing endometrial dysfunction and leiomyomas.
Brennan A; Hickey M
Med J Aust; 2018 Feb; 208(2):90-95. PubMed ID: 29385977
[TBL] [Abstract][Full Text] [Related]
38. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Reid PC; Virtanen-Kari S
BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
[TBL] [Abstract][Full Text] [Related]
39. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
40. [Medical treatment of idiopathic menorrhagia].
Graesslin O; Derniaux E
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S384-97. PubMed ID: 19268217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
